Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dendreon's Q1 Earnings Preview: Meet, Beat, or Miss?
see
Saturday, April 30, 2011 - 9:54am
tags:
Dendreon, earnings
Regeneron Pharmaceuticals Shares Plunged: What You Need to Know
Motley Fool
Saturday, April 30, 2011 - 9:52am
tags:
Regeneron, Zaltrap, macular degeneration, Bayer
Roche Holding’s Avastin Treatment Effective for Blindness in Study
Bloomberg
Saturday, April 30, 2011 - 9:51am
tags:
Roche, Avastin, age-related macular degeneration
Oncothyreon raising $40M in stock sale
bizjournals.com
Saturday, April 30, 2011 - 9:49am
tags:
Oncothyreon
Coronations for New Drug Royalty
Motley Fool
Saturday, April 30, 2011 - 9:49am
tags:
Vertex Pharmaceuticals, Cell Therapeutics, Telaprevir, hepatitis C
Has Vertex Peaked?
Minyanville
Friday, April 29, 2011 - 12:11pm
tags:
Vertex Pharmaceuticals, hepatitis C, Telaprevir
Merck Decides it Hearts Consumer Health After All
WSJ Online
Friday, April 29, 2011 - 12:10pm
tags:
Merck, OTC, Schering Plough
Is Abbott Laboratories a Stock for the Long Term?
Motley Fool
Friday, April 29, 2011 - 12:06pm
tags:
Abbott Laboratories
Judge To Issue Ruling In Generic Lipitor Case Next Week
NASDAQ.com
Friday, April 29, 2011 - 11:21am
tags:
generics, Pfizer, Lipitor, Mylan, Ranbaxy
ImmunoGen spends more on preclinical cancer drugs in 3rd-quarter and reports larger loss
Yahoo/AP
Friday, April 29, 2011 - 11:20am
tags:
Immunogen, earnings
[video] The Next Big Thing In Biotech: Dendreon, Avanir
TheStreet.com
Friday, April 29, 2011 - 11:19am
tags:
Dendreon, Avanir
Spectrum Pharma: Fusilev Bubble Will Burst
TheStreet.com
Friday, April 29, 2011 - 11:16am
tags:
Fusilev, Spectrum Pharmaceuticals, colon cancer
EU probes whether deal to keep generic Provigil off European market broke competition rules
Yahoo/AP
Friday, April 29, 2011 - 11:14am
tags:
generics, Provigil, Europe, Teva Pharmaceuticals, Cephalon
Allergan Must Pay $212M Over Botox Side Effects
Pharmalot
Friday, April 29, 2011 - 10:18am
tags:
Allergan, Botox, settlements
Are Top-Earning Pharma CEOs (We Mean You, William Weldon) Worth the $$$?
WSJ Online
Friday, April 29, 2011 - 10:17am
tags:
Pharma CEOs, executive pay, William Weldon, JNJ
4-Star Stocks Poised to Pop: AstraZeneca
Motley Fool
Friday, April 29, 2011 - 10:16am
tags:
AstraZeneca
Merck Profit Tops Analyst Estimates on Higher Drug Sales
Bloomberg
Friday, April 29, 2011 - 10:15am
tags:
Merck, earnings
Human Genome Sciences books bigger 1Q loss
Yahoo/AP
Thursday, April 28, 2011 - 10:05pm
tags:
Human Genome Sciences, earnings
1 Year to P-Day, Bristol-Myers Squibb Looks Just Fine
Motley Fool
Thursday, April 28, 2011 - 10:04pm
tags:
Plavix, patents, Bristol-Myers Squibb
FDA panel unanimously favors approval for experimental hepatitis drug from Vertex Pharma
Yahoo/AP
Thursday, April 28, 2011 - 10:01pm
tags:
FDA, Vertex Pharmaceuticals, advisory panels, hepatitis C, Telaprevir

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.